# Viatris Inc. (VTRS) stock: price and valuation

URL: https://funkfolio.com/stock/VTRS

> Viatris Inc. (VTRS) trades at $20.45, is worth $23.45B and scores 28/100. Valuation against its own history and up to 20 years of financials.

---

## Viatris Inc. (VTRS)

Viatris Inc. (VTRS) is a healthcare company (drug manufacturers - specialty & generic) based in the United States. The share price is $20.45, down 1.40% on the day, which values the company at $23.45B. Price as of 17 Nov 2026, 23:32 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $20.45 −1.40% today
- **Market value:** $23.45B
- **Forward P/E:** 7.5×
- **Dividend yield:** 2.31%
- **Funk Score:** 28/100
- **Against its own history:** Well above its usual price usual price $10.51
- **200-week average:** $11.85 73% above
- **Sector:** Healthcare

Figures as of 17 Nov 2026, 23:32 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Viatris Inc. in more detail

VTRS trades at 7.5× next year's expected earnings, 1.6× sales. Measured against its own history, the price is 95% above what its usual multiples would imply ($10.51) — well above its usual price. It sits 73% above its 200-week average of $11.85.

Over the last five fiscal years Viatris Inc. has compounded revenue 3.9% a year, free cash flow 13.4% a year. Its Funk Score is 28 out of 100 (financial strength 1.4, profitability 3.6, growth 2.9, value 3.3, each out of 10).

In its favour: Share count keeps falling. Worth checking: Altman Z in the distress zone; Revenue is shrinking.

9 of the superinvestors tracked here hold VTRS, including Christopher Davis (5.5% of the portfolio), Anthony Bozza (3.2% of the portfolio), Larry Robbins (3.1% of the portfolio).

### Superinvestors holding VTRS

9 of the investors tracked here report a position in their latest 13F filing.

- [Christopher Davis Davis Advisors](https://funkfolio.com/gurus/christopher-davis) 5.54% of portfolio · $1.3B · trimmed · Q3 2026
- [Anthony Bozza Lakewood Capital](https://funkfolio.com/gurus/anthony-bozza) 3.24% of portfolio · $60.5M · trimmed · Q3 2026
- [Larry Robbins Glenview Capital Management](https://funkfolio.com/gurus/larry-robbins) 3.13% of portfolio · $156.9M · added · Q2 2026
- [Bill Miller (founder) Miller Value Partners](https://funkfolio.com/gurus/bill-miller) 2.82% of portfolio · $13M · Q3 2026
- [Harry Burn Sound Shore Management](https://funkfolio.com/gurus/harry-burn) 2.54% of portfolio · $81.3M · new · Q3 2026
- [David Einhorn Greenlight Capital](https://funkfolio.com/gurus/david-einhorn) 1.13% of portfolio · $44M · added · Q2 2026
- [Louis Bacon Moore Capital Management](https://funkfolio.com/gurus/louis-bacon) 0.31% of portfolio · $11.1M · trimmed · Q3 2026
- [Josef Lakonishok LSV Asset Management](https://funkfolio.com/gurus/josef-lakonishok) 0.28% of portfolio · $148.6M · trimmed · Q3 2026
- [Joel Greenblatt Gotham Asset Management](https://funkfolio.com/gurus/joel-greenblatt) 0.16% of portfolio · $69.5M · trimmed · Q2 2026

### Health Care companies of similar size

- [West Pharmaceutical Services WST](https://funkfolio.com/stock/WST)
- [Quest Diagnostics DGX](https://funkfolio.com/stock/DGX)
- [STERIS STE](https://funkfolio.com/stock/STE)
- [Insmed INSM](https://funkfolio.com/stock/INSM)
- [United Therapeutics UTHR](https://funkfolio.com/stock/UTHR)
- [Incyte INCY](https://funkfolio.com/stock/INCY)
- [Tenet Healthcare THC](https://funkfolio.com/stock/THC)
- [BioNTech BNTX](https://funkfolio.com/stock/BNTX)
- [Guardant Health GH](https://funkfolio.com/stock/GH)
- [Alnylam Pharmaceuticals ALNY](https://funkfolio.com/stock/ALNY)
- [Zimmer Biomet Holdings ZBH](https://funkfolio.com/stock/ZBH)
- [Medpace Holdings MEDP](https://funkfolio.com/stock/MEDP)

Side by side: [VTRS vs THC (Viatris Inc. vs Tenet Healthcare)](https://funkfolio.com/compare/thc-vs-vtrs) [VTRS vs INCY (Viatris Inc. vs Incyte)](https://funkfolio.com/compare/incy-vs-vtrs) [VTRS vs UTHR (Viatris Inc. vs United Therapeutics)](https://funkfolio.com/compare/uthr-vs-vtrs) [VTRS vs BNTX (Viatris Inc. vs BioNTech)](https://funkfolio.com/compare/bntx-vs-vtrs) [VTRS vs INSM (Viatris Inc. vs Insmed)](https://funkfolio.com/compare/insm-vs-vtrs)

[All health care companies by market value](https://funkfolio.com/companies/sector/health-care) [Largest companies in the United States](https://funkfolio.com/companies/country/united-states) [All stocks A–Z](https://funkfolio.com/stocks)

### Viatris Inc. (VTRS): questions and answers

**What is VTRS's PEG ratio?**

Viatris Inc.'s PEG ratio is 3.77 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

**What is Viatris Inc.'s market cap?**

Viatris Inc. is valued at $23.45B at a share price of $20.45.

**Is VTRS overvalued or undervalued?**

Against its own history, VTRS is well above its usual price: the price is 95% above the $10.51 implied by the median multiples it has traded at (price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is VTRS above its 200-week moving average?**

Yes. VTRS is 72.6% above its 200-week average of $11.85. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is Viatris Inc. growing?**

Over the last five fiscal years Viatris Inc.'s revenue grew 3.9% a year.

**Does VTRS pay a dividend?**

Yes. Viatris Inc.'s dividend yield is 2.31%, or $0.48 a share a year, paying out 960% of earnings.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Viatris Inc. (VTRS) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/VTRS

Underlying data: Yahoo Finance; company filings with the SEC.
